Published in Virology on July 29, 2010
Enteric bacteria promote human and mouse norovirus infection of B cells. Science (2014) 3.13
Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci U S A (2010) 1.96
Advances in norovirus biology. Cell Host Microbe (2014) 1.45
Replication of human noroviruses in stem cell-derived human enteroids. Science (2016) 1.44
Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology. Virology (2011) 1.24
Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23
Challenges of culturing human norovirus in three-dimensional organoid intestinal cell culture models. PLoS One (2013) 1.15
Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response. PLoS Pathog (2012) 1.13
Experimental inoculation of juvenile rhesus macaques with primate enteric caliciviruses. PLoS One (2012) 1.10
Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication. J Virol (2012) 1.09
Human norovirus culture in B cells. Nat Protoc (2015) 1.08
Failure of propagation of human norovirus in intestinal epithelial cells with microvilli grown in three-dimensional cultures. Arch Virol (2013) 1.01
Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol (2015) 1.01
In vitro whole-virus binding of a norovirus genogroup II genotype 4 strain to cells of the lamina propria and Brunner's glands in the human duodenum. J Virol (2011) 0.96
A working model of how noroviruses infect the intestine. PLoS Pathog (2015) 0.95
Infection of calves with bovine norovirus GIII.1 strain Jena virus: an experimental model to study the pathogenesis of norovirus infection. J Virol (2011) 0.94
Identification of RNA-protein interaction networks involved in the norovirus life cycle. J Virol (2012) 0.92
The dynamics of norovirus outbreak epidemics: recent insights. Int J Environ Res Public Health (2011) 0.92
Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age. J Gen Virol (2013) 0.91
Human norovirus infection of caco-2 cells grown as a three-dimensional tissue structure. J Water Health (2011) 0.90
Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology. J Virol (2015) 0.90
Effect of hypochlorite-based disinfectants on inactivation of murine norovirus and attempt to eliminate or prevent infection in mice by addition to drinking water. Exp Anim (2013) 0.85
Identification of a novel cellular target and a co-factor for norovirus infection - B cells & commensal bacteria. Gut Microbes (2015) 0.85
Isolation and Analysis of Rare Norovirus Recombinants from Coinfected Mice Using Drop-Based Microfluidics. J Virol (2015) 0.78
Effect of temperature and relative humidity on the survival of foodborne viruses during food storage. Appl Environ Microbiol (2015) 0.77
Recent advances in understanding norovirus pathogenesis. J Med Virol (2016) 0.77
Norovirus antagonism of B-cell antigen presentation results in impaired control of acute infection. Mucosal Immunol (2016) 0.76
Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response. J Virol (2016) 0.76
Human norovirus detection and production, quantification, and storage of virus-like particles. Curr Protoc Microbiol (2013) 0.75
Recent advances in understanding noroviruses. F1000Res (2017) 0.75
Norovirus Gastroenteritis in a Birth Cohort in Southern India. PLoS One (2016) 0.75
Chronic norovirus infection and common variable immunodeficiency. Clin Exp Immunol (2016) 0.75
Norovirus vaccines: Correlates of protection, challenges and limitations. Hum Vaccin Immunother (2016) 0.75
Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci U S A (2016) 0.75
The major targets of acute norovirus infection are immune cells in the gut-associated lymphoid tissue. Nat Microbiol (2017) 0.75
Food-related illness and death in the United States. Emerg Infect Dis (1999) 39.22
Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (2005) 8.97
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Norovirus gastroenteritis. N Engl J Med (2009) 7.66
Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis (2008) 7.48
Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07
Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol (2004) 6.35
STAT1-dependent innate immunity to a Norwalk-like virus. Science (2003) 6.35
Sequence and genomic organization of Norwalk virus. Virology (1993) 6.25
Origin of the lamina propria dendritic cell network. Immunity (2009) 5.95
Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity (2009) 5.43
Molecular epidemiology of "Norwalk-like viruses" in outbreaks of gastroenteritis in the United States. J Infect Dis (1998) 5.32
Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09
Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med (2006) 4.91
Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med (1977) 4.80
Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood (1989) 4.76
Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41
Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology (2002) 4.13
Murine norovirus: a model system to study norovirus biology and pathogenesis. J Virol (2006) 3.91
Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med (2008) 3.74
Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70
Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J Virol (2006) 3.02
Norwalk virus open reading frame 3 encodes a minor structural protein. J Virol (2000) 2.96
Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol (2001) 2.85
Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem (2005) 2.70
Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol (2007) 2.68
Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol (1993) 2.58
Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J Virol (1996) 2.51
Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34
Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line. Virology (2006) 2.23
In vitro cell culture infectivity assay for human noroviruses. Emerg Infect Dis (2007) 2.07
Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells. J Virol (2007) 1.89
Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev (2005) 1.83
Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol (2010) 1.78
Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J Virol (2007) 1.70
Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66
Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J Virol (2009) 1.61
Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56
Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood (2006) 1.27
Investigation of norovirus replication in a human cell line. Arch Virol (2006) 1.24
Development of an immunomagnetic capture reverse transcription-PCR assay for the detection of Norwalk virus. J Virol Methods (2000) 1.24
Rotavirus: to the gut and beyond! Curr Opin Gastroenterol (2007) 1.23
Detection, genetic characterization, and quantification of norovirus RNA from sera of children with gastroenteritis. J Clin Virol (2009) 1.23
Murine norovirus, a recently discovered and highly prevalent viral agent of mice. Lab Anim (NY) (2008) 1.19
Type I and type II interferons inhibit the translation of murine norovirus proteins. J Virol (2009) 1.18
Role of mucosal dendritic cells in inflammatory bowel disease. World J Gastroenterol (2008) 1.04
Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol (2005) 1.01
Interaction of rotavirus with human peripheral blood mononuclear cells: plasmacytoid dendritic cells play a role in stimulating memory rotavirus specific T cells in vitro. Virology (2007) 0.94
Toll-like receptor 4-dependent activation of myeloid dendritic cells by leukocidin of Staphylococcus aureus. Microbes Infect (2008) 0.90
Norovirus gastroenteritis. N Engl J Med (2009) 7.66
Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09
Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med (2002) 3.86
Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78
Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70
Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15
Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity (2004) 3.10
Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) (2002) 2.75
Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.59
Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A (2008) 2.54
Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Thromb Vasc Biol (2005) 2.51
Rotavirus antigenaemia and viraemia: a common event? Lancet (2003) 2.51
Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50
The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am (2006) 2.49
Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol (2009) 2.44
Noroviruses everywhere: has something changed? Curr Opin Infect Dis (2006) 2.44
Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis (2006) 2.43
The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.43
The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol (2003) 2.38
Structural requirements for the assembly of Norwalk virus-like particles. J Virol (2002) 2.38
Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn (2009) 2.35
Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg (2009) 2.31
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
Prevalence of peg-shaped maxillary permanent lateral incisors: A meta-analysis. Am J Orthod Dentofacial Orthop (2013) 2.14
An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells. Blood (2011) 2.10
X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A (2006) 2.09
Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta (2009) 2.08
Rotaviruses: from pathogenesis to vaccination. Gastroenterology (2009) 2.05
Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med (2011) 2.04
Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. Cancer Res (2002) 1.96
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther (2008) 1.90
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol (2003) 1.89
Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect (2005) 1.83
Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis (2007) 1.83
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine (2003) 1.83
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A (2007) 1.81
Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79
HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol (2002) 1.78
Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med (2010) 1.73
Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71
Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2010) 1.69
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med (2006) 1.68
Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65
Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63
ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther (2010) 1.63
MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med (2011) 1.59
Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer (2006) 1.59
Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56
Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol (2005) 1.53
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53
Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol (2006) 1.51
Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med (2009) 1.51
Aichi virus, norovirus, astrovirus, enterovirus, and rotavirus involved in clinical cases from a French oyster-related gastroenteritis outbreak. J Clin Microbiol (2008) 1.50
Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol (2014) 1.49
Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48
Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J Infect Dis (2013) 1.46
Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res (2006) 1.45
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine (2009) 1.44
Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res (2007) 1.43
Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43
Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol (2006) 1.43
Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med (2010) 1.43
Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer (2010) 1.43
Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42
Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res (2008) 1.41
Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40
Burden of illness in the first 3 years of life in an Indian slum. J Trop Pediatr (2009) 1.40
X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution. J Virol (2006) 1.37
Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit (2005) 1.37
Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets (2011) 1.36
Widespread outbreak of norovirus gastroenteritis among evacuees of Hurricane Katrina residing in a large "megashelter" in Houston, Texas: lessons learned for prevention. Clin Infect Dis (2007) 1.34
Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis (2007) 1.33
Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction (2003) 1.33